Back to News
Market Impact: 0.4

No compelling evidence for EU veto of ETraveli, Booking tells court

BKNG
Antitrust & CompetitionRegulation & LegislationM&A & RestructuringLegal & LitigationTechnology & InnovationTravel & Leisure
No compelling evidence for EU veto of ETraveli, Booking tells court

Booking Holdings is challenging the European Union's 2023 antitrust veto of its 1.63-billion-euro ETraveli acquisition, asserting that regulators failed to provide clear, compelling evidence of anti-competitive harm and conducted an unsound market analysis. The EU, however, maintains its decision was crucial to prevent Booking from entrenching its dominant position and stifling competition in the online travel market, reflecting increased scrutiny on 'killer acquisitions.' This legal contest highlights the ongoing regulatory pressure on major tech firms regarding market consolidation and competitive practices in Europe.

Analysis

Booking Holdings is actively contesting the European Union's 2023 antitrust veto of its proposed €1.63 billion acquisition of ETraveli, arguing that regulators failed to provide clear evidence of anti-competitive harm. In court, Booking's legal counsel asserted the European Commission's decision relied on "speculation" and buzzwords like "ecosystems" and "network effects" rather than a sound analysis of market conditions with and without the merger. Conversely, the EU Commission maintains its stance, stating the deal was blocked to prevent the entrenchment of Booking's dominant market position, which would make it significantly more difficult for smaller rivals to compete for both customers and hotel partners. This legal challenge highlights a broader regulatory trend of increased scrutiny over "killer acquisitions" by dominant tech firms in Europe, making the outcome of case T-1139/23 a potentially significant precedent for future M&A activity in the sector. The moderately negative sentiment score (-0.4) reflects the uncertainty and regulatory headwinds this litigation imposes on Booking's inorganic growth strategy.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo